固有免疫分子NLRC5保护小鼠免受螺杆菌诱导的胃淋巴组织形成
该研究探讨固有免疫分子NLRC5在螺杆菌感染中的免疫调节作用。结果显示,幽门螺杆菌感染者胃黏膜NLRC5 mRNA显著升高且与胃炎严重程度相关;NLRC5缺失的巨噬细胞对螺杆菌产生更高水平的趋化因子和细胞因子;慢性猫螺杆菌感染3个月后,髓系NLRC5缺失小鼠出现胃增生、脾肿大、血清抗体滴度升高及表达CD19的胃B细胞滤泡增多,具有黏膜相关淋巴组织淋巴瘤特征。结论:NLRC5是螺杆菌感染中胃炎症和黏膜淋巴组织形成的负调控因子,巨噬细胞NLRC5信号异常可促进慢性螺杆菌感染期间的B细胞淋巴瘤发生。
要点
- 幽门螺杆菌感染者胃黏膜NLRC5 mRNA显著升高,且与胃炎严重程度相关。
- NLRC5缺失巨噬细胞对螺杆菌产生更高水平的趋化因子和细胞因子。
- 髓系NLRC5缺失小鼠慢性螺杆菌感染后出现胃增生、脾肿大和淋巴瘤样B细胞滤泡。
核心结论
- NLRC5是螺杆菌感染中胃炎症和黏膜淋巴组织形成的负调控因子。
- 巨噬细胞NLRC5信号异常可促进慢性螺杆菌感染期间的B细胞淋巴瘤发生。
研究设计与样本
- 获取30例澳大利亚患者的胃活检组织。
- 使用髓系NLRC5缺失小鼠(Nlrc5møKO)和对照小鼠,部分灌胃幽门螺杆菌SS1或猫螺杆菌,3个月后收集胃、脾、血清及骨髓来源巨噬细胞。
- 分析人和小鼠胃组织及小鼠巨噬细胞(组织学、免疫组化、免疫印迹、定量PCR)。
- 将THP-1细胞(人巨噬细胞对照)和CRISPR-Cas9基因编辑的NLRC5-/- THP-1细胞与螺杆菌孵育,分析基因表达和细胞因子产生。
主要发现
- 幽门螺杆菌感染者胃组织NLRC5 mRNA水平显著高于未感染者(P < .01),且与胃炎严重程度相关(P < .05)。
- NLRC5-/- THP-1巨噬细胞对幽门螺杆菌产生的趋化因子和细胞因子水平显著高于对照THP-1细胞(P < .05)。
- 猫螺杆菌感染3个月后,Nlrc5mø-KO小鼠出现胃增生(P < .0001)、脾肿大(P < .0001)和血清抗体滴度升高(P < .01),而对照小鼠无此表现。
- 慢性猫螺杆菌感染的Nlrc5mø-KO小鼠胃内表达CD19的B细胞滤泡数量增加(P < .0001),具有黏膜相关淋巴组织淋巴瘤特征。
- 在Nlrc5mø-KO小鼠中鉴定出B细胞激活因子是促进B细胞过度增殖的蛋白。
临床怎么用
- NLRC5可作为螺杆菌相关胃炎和黏膜淋巴组织形成的潜在免疫调节靶点。
- 巨噬细胞NLRC5信号异常可能提示慢性螺杆菌感染中B细胞淋巴瘤发生风险。
局限性
- 人胃活检样本量有限(30例)。
- 动物模型使用猫螺杆菌和幽门螺杆菌SS1,结果外推到人需谨慎。
- 研究未报告NLRC5调控B细胞激活因子的具体分子机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Helicobacter pylori induces strong inflammatory responses that are directed at clearing the infection, but if not controlled, these responses can be harmful to the host. We investigated the immune-regulatory effects of the innate immune molecule, nucleotide-binding oligomerization domain-like receptors (NLR) family CARD domain-containing 5 (NLRC5), in patients and mice with Helicobacter infection. METHODS: We obtained gastric biopsies from 30 patients in Australia. We performed studies with mice that lack NLRC5 in the myeloid linage (Nlrc5møKO) and mice without Nlrc5 gene disruption (controls). Some mice were gavaged with H pylori SS1 or Helicobacter felis; 3 months later, stomachs, spleens, and sera were collected, along with macrophages derived from bone marrow. Human and mouse gastric tissues and mouse macrophages were analyzed by histology, immunohistochemistry, immunoblots, and quantitative polymerase chain reaction. THP-1 cells (human macrophages, controls) and NLRC5-/- THP-1 cells (generated by CRISPR-Cas9 gene editing) were incubated with Helicobacter and gene expression and production of cytokines were analyzed. RESULTS: Levels of NLRC5 messenger RNA were significantly increased in gastric tissues from patients with H pylori infection, compared with patients without infection (P < .01), and correlated with gastritis severity (P < .05). H pylori bacteria induced significantly higher levels of chemokine and cytokine production by NLRC5-/- THP-1 macrophages than by control THP-1 cells (P < .05). After 3 months of infection with H felis, Nlrc5mø-KO mice developed gastric hyperplasia (P < .0001), splenomegaly (P < .0001), and increased serum antibody titers (P < .01), whereas control mice did not. Nlrc5mø-KO mice with chronic H felis infection had increased numbers of gastric B-cell follicles expressing CD19 (P < .0001); these follicles had features of mucosa-associated lymphoid tissue lymphoma. We identified B-cell-activating factor as a protein that promoted B-cell hyperproliferation in Nlrc5mø-KO mice. CONCLUSIONS: NLRC5 is a negative regulator of gastric inflammation and mucosal lymphoid formation in response to Helicobacter infection. Aberrant NLRC5 signaling in macrophages can promote B-cell lymphomagenesis during chronic Helicobacter infection.
引用
- Chonwerawong M, Ferrand J, Chaudhry HM, et al. Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid Tissue. Gastroenterology. 2020. PMID: 32169428. doi:10.1053/j.gastro.2020.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。